Parvovirus B19 lytically infects erythroid progenitor cells and thereby causes cessation of
erythropoiesis in infected individuals. Anemia develops only if red cell turnover is increased …

Parvovirus B19, the only known human pathogenic parvovirus, is highly tropic to human
bone marrow and replicates only in erythroid progenitor cells. The basis of this erythroid …

We report the results of a survey of parvovirus B19 infection carried out with the aim to
evaluate the frequency and the role of this infection in bone marrow transplant (BMT) …

Primary parvovirus B19 infection is an infrequent, but serious and treatable, cause of chronic
anemia in immunocompromised hosts. Many compromised hosts have preexisting antibody …

Abstract Human parvovirus B19 (B19) infection causes human bone marrow failure, by
affecting erythroid‐lineage cells which are well‐known target cells for B19. The anaemia …

Parvovirus B19, the only known human pathogenic parvovirus, is highly tropic to human
bone marrow and replicates only in erythroid progenitor cells. The basis of this erythroid …

Human parvovirus B19 is a very common infectious pathogen in humans. In healthy
subjects, B19 infection is the cause of a self‐limiting subclinical erythroid aplasia, followed …

Due to the preparative regimen necessary, bone marrow transplantation (BMT) consistently
results in severe immunodeficiency, often associated with anaemia, leukopenia and …

Chronic parvovirus B19 infection in the immunocompromised host may cause severe
anaemia secondary to failure of erythropoiesis. This has been previously documented in …

Parvovirus B19 is a single‐stranded DNA virus which preferentially targets the erythroblast
resulting in red cell aplasia, which is temporary in immunocompetent persons. Since the …